期刊文献+

血清泌乳素水平与帕金森病痴呆的相关性研究 被引量:2

A study of relationship between blood serum prolactin level and parkinson's disease with dementia
下载PDF
导出
摘要 目的探讨帕金森病痴呆(PDD)患者及帕金森病(PD)与血清泌乳素(PRL)的关系。方法测定30例在我院门诊体检中心进行体检的正常健康老人(正常对照组),PD非痴呆患者(PD组)30例及帕金森病痴呆(PDD组)患者30例的血清PRL水平。并采用简明智能状况评价量表(MMSE)把PD患者分别划为痴呆组和非痴呆组。分别比较各组的血清PRL水平。结果PD非痴呆组者的血清PRL平均水平为6.49±67μg/L,低于正常对照组11.77±2.38μg/L;PDD组平均PRL水平为1.94±0.83μg/L,明显低于PD非痴呆组6.49±1.67μg/L。结论PDD患者的血清PRL水平是降低的。PDD患者的痴呆表现越重,血清PRL水平越低,二者呈高度相关。 Objective To investigate the relationship of blood serum prolaetin (PRL) level between parkinson's disease with dementia (PDD) patients and parkinson's disease (PD) patients. Methods We detected the blood serum PRL level of 30 normal healthy old people (normal control group) who preceded the physical examination in the physical examination centre of our hospital,and 30 parkinson's disease patients (PD group) and 30 parkinson's disease with dementia (PDD group) patients. Mini-mental state examination (MMSE) was used to divide the PD patients into the dementia group and non-dementia group. We compared the serum PRL level of each group respectively. Results Average serum PRL level of the parkinson's disease group was 6.49± 1.67μg/L, which was lower than normal control group 11.77±2.38μg/L;Average serum PRL level of the PDD group was 1.94±0.83μg/L,obviously lower than PD group 6.49± 1.67μg/L. Conclusion The serum PRL level in PDD patients is decreased. The more severe dementia symptom in PDD patients is,the lower serum PRL level is,and they have high correlation.
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2007年第3期291-293,共3页 Journal of Apoplexy and Nervous Diseases
关键词 痴呆 帕金森病 泌乳素 Dementia Parkinson's disease Prolactin
  • 相关文献

参考文献10

  • 1Scatton B,Javoy-Agid F,Rouquier L,et al.Reduction of cortical dopamine.noradrenaline,serotonin and their metabolites in Parkinson's disease[J].Brain Res,1983,275:321-328.
  • 2Morttimer JA,Pirozzolo FJ,Hansch EC,et al.Relationship of motor symptoms to intellectual deficits in Parkinson's dease[J].Neurology,1982,32:133-137.
  • 3Ruberg M,Agid Y.Dementia in Parkinson's disease[A].Iverson L,Iverson S,Snyder S,et al.Handbook of psychopharmacology[M].New York.Plenum Press,1988.157-206.
  • 4Perry EK,Curtis M,Dick DJ,et al.Cholinergic correlates of cognitive impairment in Parkinson's disease:comparisions with Alzheimer's disease[J].Neurol Neurosurg Psychiatry,1985,48:413-421.
  • 5Perry EK,Irving D,Kerwin JM,et al.Cholinergic transmitter and neurotropic activities in Lewy body dementia:similarity to Parkinson's and distinction from Alzheimer disease[J].Alzheimer Dis Assoc Disord,1993,7:69-79.
  • 6Dubois B,Ruberg M,Javoy-Agid F,et al.A subcortico-cortical cholinergic system is affected in Parkinson's disease[J].Brain Res,1983,288:213-218.
  • 7赵永波,王乔树.帕金森病痴呆[J].神经疾病与精神卫生,2004,4(1):53-56. 被引量:5
  • 8Burghaus L,Sehutz U,Krempel U,et al.Loss of nicotinic acetycholine receptor subunitsα4 and α7 in the cerebral cortex of Parkinson patients[J].Parkinsonism and Related Disorder,2003,9(1):243.
  • 9Ben-Jonathan N,Hnasko R.Dopamine as a prolactin(PRL) inhabitor[J].Endoer Rev,2002,22(6):724.
  • 10Winkler AS.Serum prolactin levels in Parkinson's disease and multiple system atrophy[J].Clin Auton Res,22,12(5):393.

二级参考文献46

  • 1[1]Cummings JL.Intellectual impairment in Parkinson's disease clinical,pathologic,and biochemical correlates[J].J Geriatr Psychiatry Neurol,1988,1:24-36.
  • 2[2]Mayeux R,Denaro J,Hemenegildo N,et al.A populationbased investigation of Parkinson's disease with and without dementia:relationship to age and gender[J].Arch Neurol,1992,49:492-497.
  • 3[3]Mindham RH,Ahmed SW,Clough CG.A controlled study of dementia in Parkinson's disease [J].J Neurol Neurosurg Psychiatry,1982,45:969-974.
  • 4[4]Aarsland D,Andersen K,Larsen JP,et al.Risk of dementia in Pa rkinson's disease a community-based,prospective study [J].Neurology,2001,56:730-736.
  • 5[5]Aarsland D,Tandberg E,Larsen JP,et al.Frequency of dementia inParkinsondisease[J].ArchNeurol,1996,53:538-542.
  • 6[6]Inzelberg R,Chapman J,Treves TA,et al.Apolipoprotein E4 in Parkinson disease and dementia:new data and meta-analysis of published studies [J].Alzheimer Dis Assoc Disord,1998,12:45-48.
  • 7[7]Levy G,Schupf N,Tang MX,et al.Combined effect of age and severity on the risk of dementia in Parkinson' s disease [J].AnnNeurol,2002,51:722-729.
  • 8[8]Marder K,Leung D,Tang M,et al.Are demented patients with Parkinson's disease accurately reflected in prevalence survey? A survival analysis [J].Neurology,1991,41:1240-1243.
  • 9[9]Litvan I,Mohr E,Williams J,et al.Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease [J].J Neurol Neurosurg Psychiatry,1991,54:25-29.
  • 10[10]Stern Y,Richards M,Sano M,et al.Comparison of cognitive changes in patients with Alzheimer's and Parkinson's disease [J].ArchNeurol,1993,50:1040-1045.

共引文献4

同被引文献10

引证文献2

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部